Tuesday, November 3, 2009

Pharmacies on Advance Compounding of Tamiflu Oral Suspension

Commercially manufactured Tamiflu for Oral Suspension (12 mg/mL) is the preferred product for pediatric and adult patients who have difficulty swallowing capsules. However, preparation of an oral suspension from the 75 mg Tamiflu Capsules, as described in the FDA-approved labeling resulting in a concentration of 15 mg/ml, may be necessary when the commercial suspension, Tamiflu for Oral Suspension (12 mg/ml),for more FDA...

No comments:

Post a Comment